Evidence map›Paper›PMID 23498041›Full record

ArticleSouth African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde2012

Antiretroviral treatment uptake in patients with HIV-associated TB attending co-located TB and ART services.

Mweete Debra Nglazi, Richard Kaplan, Judy Caldwell, Neshaan Peton, Stephen D Lawn, Robin Wood, Linda-Gail Bekker

Abstract readComparative Study
In one paragraph

Article in South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mweete Debra NglaziUniversity of Cape Town, South Africa. Mweete.Nglazi@hiv-research.org.za
Richard Kaplan
Judy Caldwell
Neshaan Peton
Stephen D Lawn
Robin Wood
Linda-Gail Bekker

Funding

Observational Antiretroviral Studies In Southern Africa (OASIS) CollaborationU01AI069924 · NIAID · UNIVERSITAT BERN · PI Cleophas Chimbetete, Mary-Ann Davies · 2006 to 2026
$55.9M
Optimizing HIV Care in Less Developed CountriesR01AI058736 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Kenneth Alan Freedberg, Emily Parker Hyle · 2004 to 2026
$21.5M
NIAID NIH HHS 5 R01AI058736-02NIAID NIH HHS 5 R01AI069924-02NIAID NIH HHS R01 AI058736NIAID NIH HHS U01 AI069924Wellcome Trust
6 · The paper itself

Abstract

backgroundDelivery of integrated care for patients with HIV-associated TB is challenging. We assessed the uptake and timing of antiretroviral treatment (ART) among eligible patients attending a primary care service with co-located ART and TB clinics.

methodsIn a retrospective cohort study, all HIV-associated TB patients (≥18 years old) who commenced TB treatment in 2010 were included. Data were analysed using basic descriptive statistics and log-binomial regression analysis.

resultsOf a total of 497 patients diagnosed with HIV-associated TB, 274 were eligible to start ART for the first time (median CD4 count, 159 cells/µl). ART was started during TB treatment by 220 (80.3%) patients. Among the 54 (19.7%) who did not start ART, 23 (42.6%) were either lost to follow-up (LTFU) or died before enrolling for ART; 12 (22.2%) were either LTFU or died after enrolling but before starting ART; 5 (9.3%) were transferred out; and 14 (25.9%) only started ART after completion of TB treatment. The median delay between starting TB treatment and starting ART was 51 days (IQR 29 - 77). Overall, only 58.6% of patients started ART within 8 weeks of TB treatment, and 12.7% of those with CD4 counts <50 cells/µl started ART within 2 weeks.

conclusionsIn a setting with co-located TB and ART clinics, delays to starting ART were substantial, and one-fifth of eligible patients did not start ART during TB treatment. Co-location of services alone is insufficient to permit timely initiation of ART; further measures need to be implemented to facilitate integrated treatment.

Indexed as

Patient AdmissionAdultAnti-HIV AgentsAntitubercular AgentsFemaleHIV InfectionsHumansLost to Follow-UpMaleRetrospective StudiesSouth AfricaTime FactorsTreatment OutcomeTuberculosisYoung AdultAnti-HIV AgentsAntitubercular Agents

Identifiers

PMID23498041
PMCPMC3960570

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.